# Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease

> **NCT02530931** · PHASE4 · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 23 (actual)

## Conditions studied

- Meniere's Disease

## Interventions

- **DRUG:** Gadolinium

## Key facts

- **NCT ID:** NCT02530931
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03-16
- **Primary completion:** 2020-09
- **Final completion:** 2020-09
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Recruitment problem-covid
- **Last updated:** 2020-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02530931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02530931, "Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02530931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
